2-6865638-C-G

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_207315.4(CMPK2):ā€‹c.59G>Cā€‹(p.Arg20Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000441 in 1,354,500 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00016 ( 0 hom., cov: 35)
Exomes š‘“: 0.00048 ( 3 hom. )

Consequence

CMPK2
NM_207315.4 missense

Scores

2
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.161
Variant links:
Genes affected
CMPK2 (HGNC:27015): (cytidine/uridine monophosphate kinase 2) This gene encodes one of the enzymes in the nucleotide synthesis salvage pathway that may participate in terminal differentiation of monocytic cells. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]
RSAD2 (HGNC:30908): (radical S-adenosyl methionine domain containing 2) The protein encoded by this gene is an interferon-inducible antiviral protein that belongs to the S-adenosyl-L-methionine (SAM) superfamily of enzymes. The protein plays a role in cellular antiviral response and innate immune signaling. Antiviral effects result from inhibition of viral RNA replication, interference in the secretory pathway, binding to viral proteins and dysregulation of cellular lipid metabolism. The protein has been found to inhibit both DNA and RNA viruses, including influenza virus, human immunodeficiency virus (HIV-1) and Zika virus. [provided by RefSeq, Sep 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03574875).
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CMPK2NM_207315.4 linkc.59G>C p.Arg20Pro missense_variant 1/5 ENST00000256722.10 NP_997198.2 Q5EBM0-1
CMPK2NM_001256477.1 linkc.59G>C p.Arg20Pro missense_variant 1/4 NP_001243406.1 Q5EBM0-4
CMPK2NM_001256478.1 linkc.59G>C p.Arg20Pro missense_variant 1/4 NP_001243407.1 Q5EBM0-3
CMPK2NR_046236.2 linkn.210+788G>C intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CMPK2ENST00000256722.10 linkc.59G>C p.Arg20Pro missense_variant 1/51 NM_207315.4 ENSP00000256722.5 Q5EBM0-1

Frequencies

GnomAD3 genomes
AF:
0.000158
AC:
24
AN:
151782
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000135
AC:
4
AN:
29618
Hom.:
0
AF XY:
0.000166
AC XY:
3
AN XY:
18042
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000345
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000476
AC:
573
AN:
1202718
Hom.:
3
Cov.:
38
AF XY:
0.000473
AC XY:
278
AN XY:
588036
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000353
Gnomad4 NFE exome
AF:
0.000565
Gnomad4 OTH exome
AF:
0.000268
GnomAD4 genome
AF:
0.000158
AC:
24
AN:
151782
Hom.:
0
Cov.:
35
AF XY:
0.000162
AC XY:
12
AN XY:
74146
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.0000656
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000309
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000170
ExAC
AF:
0.0000430
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 09, 2021The c.59G>C (p.R20P) alteration is located in exon 1 (coding exon 1) of the CMPK2 gene. This alteration results from a G to C substitution at nucleotide position 59, causing the arginine (R) at amino acid position 20 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
20
DANN
Benign
0.84
DEOGEN2
Benign
0.017
.;T;.
Eigen
Benign
-0.80
Eigen_PC
Benign
-0.92
FATHMM_MKL
Benign
0.67
D
LIST_S2
Benign
0.50
T;T;T
M_CAP
Pathogenic
0.36
D
MetaRNN
Benign
0.036
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.81
L;L;L
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-0.54
N;N;N
REVEL
Benign
0.19
Sift
Uncertain
0.012
D;D;D
Sift4G
Benign
0.10
T;T;T
Polyphen
0.96
D;P;.
Vest4
0.27
MutPred
0.28
Loss of MoRF binding (P = 0.0095);Loss of MoRF binding (P = 0.0095);Loss of MoRF binding (P = 0.0095);
MVP
0.29
MPC
0.49
ClinPred
0.073
T
GERP RS
-0.33
Varity_R
0.20
gMVP
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs760569289; hg19: chr2-7005769; API